Cargando…
Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy
BACKGROUND: Although immunotherapy (IMT) provides significant survival benefits in selected patients, approximately 10% of patients experience (serious) immune-related adverse events (irAEs). The early detection of adverse events will prevent irAEs from progressing to severe stages, and routine test...
Autores principales: | van Delft, Frederik, Muller, Mirte, Langerak, Rom, Koffijberg, Hendrik, Retèl, Valesca, van den Broek, Daan, IJzerman, Maarten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295956/ https://www.ncbi.nlm.nih.gov/pubmed/33813943 http://dx.doi.org/10.1177/0272989X211002756 |
Ejemplares similares
-
The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review
por: van Delft, Frederik, et al.
Publicado: (2020) -
Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer
por: van de Ven, Michiel, et al.
Publicado: (2022) -
Modeling strategies to analyse longitudinal biomarker data: An illustration on predicting immunotherapy non-response in non-small cell lung cancer
por: van Delft, Frederik A., et al.
Publicado: (2022) -
Whole genome sequencing in oncology: using scenario drafting to explore future developments
por: van de Ven, Michiel, et al.
Publicado: (2021) -
Comparing Strategies for Modeling Competing Risks in Discrete-Event Simulations: A Simulation Study and Illustration in Colorectal Cancer
por: Degeling, Koen, et al.
Publicado: (2018)